CCA
ALXN

Checchi Capital Advisers’s Alexion Pharmaceuticals ALXN Stock Holding History

Checchi Capital Advisers’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,464
Closed -$204K – 457
2018
Q3 		$204K Buy
+1,464
New +$184K 0.04% 422
2016
Q3 		– Sell
-1,467
Closed -$171K – 1354
2016
Q2 		$171K Sell
1,467
-62
-4% -$8.8K 0.04% 389
2016
Q1 		$213K Sell
1,529
-265
-15% -$38.9K 0.06% 321
2015
Q4 		$342K Buy
1,794
+222
+14% +$38.8K 0.11% 212
2015
Q3 		$246K Buy
1,572
+105
+7% +$19.2K 0.08% 268
2015
Q2 		$265K Sell
1,467
-228
-13% -$39.3K 0.09% 259
2015
Q1 		$294K Buy
1,695
+178
+12% +$32.2K 0.1% 227
2014
Q4 		$281K Buy
1,517
+93
+7% +$17.2K 0.11% 212
2014
Q3 		$236K Buy
+1,424
New +$234K 0.1% 219

Other funds holding ALXN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return